Another indel, the five nucleotide deletion rs138461304 in the seed region of miR-559, may disrupt targeting of ERBB2 by miR-559 [54], resulting in overexpression of ERBB2, an abnormality that has been associated with cancer [54], [55]. The gene discussed is ERBB2; the disease is cancer.